首頁 > 市場調查報告書 > 製藥

製藥企業製藥企業資料製藥企業策略

市場調查報告書

商品編碼

2055127

診斷服務市場（按服務類型分類）

Diagnostic Services Market, By Service Type (Pathology/Laboratory, and Radiology/Diagnostic Imaging, By Test Type, By Application, By End User, By Payer, By Geography )

出版日期: 2026年03月17日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，診斷服務市場規模將達到3,103億美元，到2033年將達到6,163.2億美元。預計從2026年到2033年，該市場將以10.3%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	3103億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	10.30%	2033年市場規模預測：	6163.2億美元

全球診斷服務市場是醫療保健生態系統的重要組成部分，涵蓋全面的醫學檢測、篩檢和分析服務，能夠實現疾病的精準檢測、監測和治療指南。該市場涵蓋多種診斷方法，例如臨床實驗室檢測、醫學影像服務、病理診斷服務和就地檢驗，服務對象包括醫院、診所、診斷中心和居家醫療機構。

隨著科技進步，診斷服務業正經歷著翻天覆地的變化，人工智慧、分子診斷和數位病理學等技術的融合，顯著提升了醫療檢測的準確性、速度和可及性。全球人口老化、慢性病盛行率上升、健康意識增強以及創新診斷技術的持續發展，共同推動了市場成長。醫療服務提供者越來越依賴先進的診斷服務來實現個人化醫療、改善患者預後並最佳化治療方案。遠端醫療和遠距監測功能的整合進一步拓展了診斷服務的範圍。新冠疫情尤其加速了這一擴張，凸顯了快速、準確、便捷的診斷解決方案在應對公共衛生挑戰和確保不同地區醫療服務連續性方面的重要性。

市場動態

全球診斷服務市場受多種關鍵因素驅動，這些因素共同推動全球醫療保健系統的強勁擴張。主要成長要素包括全球人口快速老化以及由此導致的糖尿病、心血管疾病、癌症和神經系統疾病等慢性病的激增，這些疾病需要持續監測和先進的診斷干預。人工智慧 (AI)、分子診斷、液態生物檢體和次世代定序(NGS) 等技術的進步，大大提高了診斷的準確性和效率，使醫療服務提供者能夠提供個人化的治療方案。預防醫學的日益普及和常規篩檢計畫的實施顯著增加了對診斷服務的需求，而政府促進疾病早期發現和醫療基礎設施建設的舉措也進一步加速了市場成長。

然而，市場面臨許多限制因素，包括先進診斷設備和流程的高成本。這造成了准入障礙，尤其是在醫療預算有限的發展中地區。嚴格的監管要求和漫長的核准流程也阻礙了新診斷技術的市場准入和應用。此外，熟練先進診斷設備操作技能的醫護人員和技術人員短缺，也為服務提供者帶來了營運方面的挑戰。

儘管有這些限制，但新興市場醫療基礎設施的擴張、對居家和即時診斷（POC）解決方案日益成長的需求，以及對精準醫療和伴隨診斷投資的增加，正在湧現出巨大的機會。數位健康技術、遠端醫療平台和遠端監測功能的整合，為市場擴張提供了廣闊的空間。此外，醫療系統對既能改善病患就醫途徑又能確保在各種醫療環境中保持診斷品質和可靠性的成本效益型解決方案的需求，進一步增強了這一潛力。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球診斷服務市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
這份全球診斷服務市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球診斷服務市場分析中使用的各種策略矩陣，更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第10章競爭格局

Siemens Healthineers AG
F. Hoffmann-La Roche Ltd
Abbott Laboratories
Thermo Fisher Scientific Inc
Quest Diagnostics Incorporated
Laboratory Corporation of America Holdings（LabCorp）
Bio-Rad Laboratories Inc
Danaher Corporation（Beckman Coulter & Cepheid）
Hologic Inc
GE HealthCare Technologies Inc
Philips Healthcare
Agilent Technologies Inc
QIAGEN NV
PerkinElmer Inc（now Revvity）
Illumina Inc

第11章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第12章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI8663

Diagnostic Services Market is estimated to be valued at USD 310.30 Bn in 2026 and is expected to reach USD 616.32 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 310.30 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	10.30%	2033 Value Projection:	USD 616.32 Bn

The global diagnostic services market represents a critical component of the healthcare ecosystem, encompassing a comprehensive range of medical testing, screening, and analytical services that enable accurate disease detection, monitoring, and treatment guidance. This market includes various diagnostic modalities such as clinical laboratory testing, medical imaging services, pathology services, and point-of-care testing solutions that serve hospitals, clinics, diagnostic centers, and home healthcare settings.

The diagnostic services sector has evolved significantly with technological advancements, incorporating artificial intelligence, molecular diagnostics, and digital pathology to enhance accuracy, speed, and accessibility of medical testing. The market's growth trajectory is driven by an aging global population, increasing prevalence of chronic diseases, rising healthcare awareness, and the continuous development of innovative diagnostic technologies. Healthcare providers increasingly rely on sophisticated diagnostic services to deliver personalized medicine, improve patient outcomes, and optimize treatment protocols. The integration of telemedicine and remote monitoring capabilities has further expanded the scope of diagnostic services, particularly accelerated by the COVID-19 pandemic which highlighted the critical importance of rapid, accurate, and accessible diagnostic solutions in managing public health challenges and ensuring continuity of healthcare delivery across diverse geographical regions.

Market Dynamics

The global diagnostic services market is propelled by several key drivers that collectively fuel its robust expansion across healthcare systems worldwide. The primary growth driver stems from the rapidly aging global population and the corresponding surge in chronic diseases such as diabetes, cardiovascular disorders, cancer, and neurological conditions, which require continuous monitoring and sophisticated diagnostic interventions. Technological advancements including artificial intelligence integration, molecular diagnostics, liquid biopsies, and next-generation sequencing have revolutionized diagnostic accuracy and efficiency, enabling healthcare providers to deliver personalized treatment approaches. The increasing adoption of preventive healthcare practices and routine screening programs has significantly expanded the demand for diagnostic services, while government initiatives promoting early disease detection and healthcare infrastructure development further accelerate market growth.

However, the market faces considerable restraints including high costs associated with advanced diagnostic equipment and procedures, which limit accessibility particularly in developing regions with constrained healthcare budgets. Stringent regulatory requirements and lengthy approval processes for new diagnostic technologies create barriers to market entry and innovation adoption. Additionally, shortage of skilled healthcare professionals and technicians capable of operating sophisticated diagnostic equipment poses operational challenges for service providers.

Despite these constraints, substantial opportunities emerge from expanding healthcare infrastructure in emerging economies, growing demand for home-based and point-of-care diagnostic solutions, and increasing investments in precision medicine and companion diagnostics. The integration of digital health technologies, telemedicine platforms, and remote monitoring capabilities presents lucrative opportunities for market expansion, particularly as healthcare systems seek cost-effective solutions that improve patient accessibility while maintaining diagnostic quality and reliability across diverse healthcare settings.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global diagnostic services market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo Fisher Scientific Inc, Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings (LabCorp), Bio-Rad Laboratories Inc, Danaher Corporation (Beckman Coulter & Cepheid), Hologic Inc, GE HealthCare Technologies Inc, Philips Healthcare, Agilent Technologies Inc, QIAGEN N.V., PerkinElmer Inc (now Revvity), and Illumina Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global diagnostic services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diagnostic services market

Market Segmentation

Service Type Insights (Revenue, USD Bn, 2021 - 2033)
Pathology/Laboratory
- Clinical Chemistry
- Hematology
- Microbiology and Cytology
- Molecular Diagnostics
- Immunodiagnostics/Immunoassay
- Others (Histopathology)
Radiology/Diagnostic Imaging
- X-ray
- Magnetic Resonance Imaging (MRI)
- Ultrasound
- Computed Tomography (CT) Scan
- Nuclear Imaging (PET, SPECT)
- Others (Mammography)
Test Type Insights (Revenue, USD Bn, 2021 - 2033)
Routine/Preventive Test
Molecular and Genetic Test
Point-of-Care Tests (POCT)
Other Specialty Test
Application Insights (Revenue, USD Bn, 2021 - 2033)
Oncology
Cardiology
Neurology
Gastroenterology
Orthopedics
Gynecology and Obstetrics
Other Applications (e.g., Infectious Diseases, Endocrinology)
End User Insights (Revenue, USD Bn, 2021 - 2033)
Hospitals and Clinics
Diagnostic Laboratories and Pathology Labs
Research and Academic Institutes
Home Healthcare/At-Home Testing
Specialized Diagnostic Centers
Payer Insights (Revenue, USD Bn, 2021 - 2033)
Public
Private
Self-Pay (Out-of-Pocket Patients)
Corporate/Employer-Sponsored Health Plans
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Siemens Healthineers AG
F. Hoffmann-La Roche Ltd
Abbott Laboratories
Thermo Fisher Scientific Inc
Quest Diagnostics Incorporated
Laboratory Corporation of America Holdings (LabCorp)
Bio-Rad Laboratories Inc
Danaher Corporation (Beckman Coulter & Cepheid)
Hologic Inc
GE HealthCare Technologies Inc
Philips Healthcare
Agilent Technologies Inc
QIAGEN N.V.
PerkinElmer Inc (now Revvity)
Illumina Inc

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Diagnostic Services Market, By Service Type
- Global Diagnostic Services Market, By Test Type
- Global Diagnostic Services Market, By Application
- Global Diagnostic Services Market, By End User
- Global Diagnostic Services Market, By Payer
- Global Diagnostic Services Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Diagnostic Services Market, By Service Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Pathology/Laboratory
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - Clinical Chemistry
  - Hematology
  - Microbiology and Cytology
  - Molecular Diagnostics
  - Immunodiagnostics/Immunoassay
  - Others (Histopathology)
Radiology/Diagnostic Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - X-ray
  - Magnetic Resonance Imaging (MRI)
  - Ultrasound
  - Computed Tomography (CT) Scan
  - Nuclear Imaging (PET, SPECT)
  - Others (Mammography)

5. Global Diagnostic Services Market, By Test Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Routine/Preventive Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Molecular and Genetic Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Point-of-Care Tests (POCT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Other Specialty Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Diagnostic Services Market, By Application, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Gastroenterology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Orthopedics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Gynecology and Obstetrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Other Applications (e.g., Infectious Diseases, Endocrinology)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Diagnostic Services Market, By End User, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Diagnostic Laboratories and Pathology Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Home Healthcare/At-Home Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Specialized Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Diagnostic Services Market, By Payer, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Public
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Self-Pay (Out-of-Pocket Patients)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Corporate/Employer-Sponsored Health Plans
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Diagnostic Services Market, By Region, 2021 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Payer, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Payer, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Payer, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Payer, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Payer, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Payer, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Siemens Healthineers AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
F. Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Quest Diagnostics Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Laboratory Corporation of America Holdings (LabCorp)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Danaher Corporation (Beckman Coulter & Cepheid)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hologic Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GE HealthCare Technologies Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Philips Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Technologies Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PerkinElmer Inc (now Revvity)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Illumina Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

診斷領域的合作與授權協議（2020-2026 年）

診斷研究綜述：2025

代謝領域的合作研究與授權協議（2019-2026）

婦科領域的合作與授權協議（2016-2026）

消化系統領域的合作與授權協議（2016-2026）

精神病學合作研究和許可協議（2019-2026）

肌肉骨骼領域的合作與授權協議（2016-2026）

腫瘤學合作研究和許可協議（2021-2026）

醫院醫療保健領域的合作與許可協議（2016-2026 年）

全球消化器官系統市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

▼

FAQ

診斷服務市場（按服務類型分類）